These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10411315)

  • 21. [The role of different E3 ubiquitin ligases in regulation of the P53 tumor suppressor protein].
    Daks AA; Melino D; Barlev NA
    Tsitologiia; 2013; 55(10):673-87. PubMed ID: 25509121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activating the ubiquitin family: UBA6 challenges the field.
    Groettrup M; Pelzer C; Schmidtke G; Hofmann K
    Trends Biochem Sci; 2008 May; 33(5):230-7. PubMed ID: 18353650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel protein-conjugating system for Ufm1, a ubiquitin-fold modifier.
    Komatsu M; Chiba T; Tatsumi K; Iemura S; Tanida I; Okazaki N; Ueno T; Kominami E; Natsume T; Tanaka K
    EMBO J; 2004 May; 23(9):1977-86. PubMed ID: 15071506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer.
    Soucy TA; Smith PG; Rolfe M
    Clin Cancer Res; 2009 Jun; 15(12):3912-6. PubMed ID: 19509147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzymes of ubiquitination and deubiquitination.
    Neutzner M; Neutzner A
    Essays Biochem; 2012; 52():37-50. PubMed ID: 22708562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assays for RING family ubiquitin ligases.
    Furukawa M; Andrews PS; Xiong Y
    Methods Mol Biol; 2005; 301():37-46. PubMed ID: 15917624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complete reconstitution of conjugation and subsequent degradation of the tumor suppressor protein p53 by purified components of the ubiquitin proteolytic system.
    Shkedy D; Gonen H; Bercovich B; Ciechanover A
    FEBS Lett; 1994 Jul; 348(2):126-30. PubMed ID: 8034027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme.
    Schwarz SE; Matuschewski K; Liakopoulos D; Scheffner M; Jentsch S
    Proc Natl Acad Sci U S A; 1998 Jan; 95(2):560-4. PubMed ID: 9435231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ubiquitination independent of E1 and E2 enzymes by bacterial effectors.
    Qiu J; Sheedlo MJ; Yu K; Tan Y; Nakayasu ES; Das C; Liu X; Luo ZQ
    Nature; 2016 May; 533(7601):120-4. PubMed ID: 27049943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of the receptor component of the IkappaBalpha-ubiquitin ligase.
    Yaron A; Hatzubai A; Davis M; Lavon I; Amit S; Manning AM; Andersen JS; Mann M; Mercurio F; Ben-Neriah Y
    Nature; 1998 Dec; 396(6711):590-4. PubMed ID: 9859996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The family of ubiquitin-conjugating enzymes (E2s): deciding between life and death of proteins.
    van Wijk SJ; Timmers HT
    FASEB J; 2010 Apr; 24(4):981-93. PubMed ID: 19940261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of ubiquitin-proteasome pathway in spermatogenesis.
    Dong LH; Ran ML; Li Z; Peng FZ; Chen B
    Yi Chuan; 2016 Sep; 38(9):791-800. PubMed ID: 27644740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional characterization of the ubiquitin variant encoded by the baculovirus Autographa californica.
    Haas AL; Katzung DJ; Reback PM; Guarino LA
    Biochemistry; 1996 Apr; 35(17):5385-94. PubMed ID: 8611528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2.
    Okuma T; Honda R; Ichikawa G; Tsumagari N; Yasuda H
    Biochem Biophys Res Commun; 1999 Jan; 254(3):693-8. PubMed ID: 9920803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ubiquitin-dependent proteolytic pathway: specificity of recognition of the proteolytic substrates.
    Ciechanover A; Schwartz AL
    Revis Biol Celular; 1989; 20():217-34. PubMed ID: 2561543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
    Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tools to investigate the ubiquitin proteasome system.
    Leestemaker Y; Ovaa H
    Drug Discov Today Technol; 2017 Dec; 26():25-31. PubMed ID: 29249239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of SUMO and Ubiquitin by ROS: Signaling and disease implications.
    Stankovic-Valentin N; Melchior F
    Mol Aspects Med; 2018 Oct; 63():3-17. PubMed ID: 30059710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ubiquitin and the SCF(Grr1) ubiquitin ligase complex are involved in the signalling pathway activated by external amino acids in Saccharomyces cerevisiae.
    Bernard F; André B
    FEBS Lett; 2001 May; 496(2-3):81-5. PubMed ID: 11356187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ubiquitin-mediated proteolytic pathway: enzymology and mechanisms of recognition of the proteolytic substrates.
    Ciechanover A; Gonen H
    Semin Cell Biol; 1990 Dec; 1(6):415-22. PubMed ID: 1966527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.